Standard Precautions Advised in Labor & Delivery to Prevent Zika

Share this content:
Standard Precautions Advised in Labor & Delivery to Prevent Zika
Standard Precautions Advised in Labor & Delivery to Prevent Zika

MONDAY, March 28, 2016 (HealthDay News) -- Standard Precautions should be used in all health care settings, including labor and delivery, in order to minimize the potential risk of transmission of Zika virus to health care personnel or other patients, according to research published in the March 25 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that sexual transmission of Zika has been documented and that Zika virus RNA has been detected in a number of body fluids, Christine K. Olson, M.D., from the CDC in Atlanta, and colleagues discuss prevention of transmission of Zika virus in labor and delivery settings.

The researchers note that the CDC recommends Standard Precautions in all health care settings to protect health care personnel and patients from Zika virus infection. Given the theoretical risk for transmission of Zika virus through contact with body fluids, the importance of maintaining appropriate infection control is emphasized. Standard Precautions represent the minimum infection prevention expectations for safe care and should be used in all health care settings, including labor and delivery settings.

"Because of the potential for exposure to large volumes of body fluids during the labor and delivery process and the sometimes unpredictable and fast-paced nature of obstetrical care, the use of Standard Precautions in these settings is essential to prevent possible transmission of Zika virus from patients to health care personnel," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths